Endocrine tumours of the gastrointestinal tract - Selected topics

Histopathology

Volumn 50, Issue 1, 2007, Pages 30-41

  Williams, G T ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Carcinoid; Diagnosis; Endocrine tumours; Gastrointestinal tract; Neuroendocrine tumours; Pathogenesis; Prognosis

Indexed keywords

APPENDIX; APPENDIX TUMOR; CELL MEMBRANE; CHROMAFFIN CELL; CLINICAL ASSESSMENT; DUODENUM; ENDOCRINE TUMOR; GASTROINTESTINAL TRACT; GASTROINTESTINAL TUMOR; HUMAN; LARGE INTESTINE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

CARCINOID TUMOR; ENTEROENDOCRINE CELLS; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33845611928     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02570.x     Document Type: Review

References (75)

1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97; 934-959.
2. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann. Surg. 2004; 240; 117-122.
3. Öberg K, Kvols L, Caplin M et al. Consensus report of the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropanreatic system. Ann. Oncol. 2004; 15; 966-973.
4. Capella C, La Rosa S, Uccella S, Billo P, Cornaggia M. Mixed endocrine-exocrine tumors of the gastrointestinal tract. Semin. Diag. Pathol. 2000; 17; 91-103.
5. Misdraji J. Neuroendocrine tumours of the appendix. Curr. Diag. Pathol. 2005; 11; 180-193.
6. Barbareschi M, Roldo C, Zamboni G et al. CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors. Am. J. Surg. Pathol. 2004; 28; 1169-1176.
7. van Eeden S, Offerhaus GJA. Historical, current and future perspectives on gastrointestinal and pancreatic endocrine tumors. Virchows Arch. 2006; 448; 1-6.
8. Stamm B, Hedinger CE, Saremaslani P. Duodenal and ampullary carcinoid tumors: a report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN I syndrome and von Recklinghausen's disease (neurofibromatosis). Virchows Arch. [A] 1986; 408; 475-489.
9. Anlauf M, Perren A, Meyer CL et al. Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterology 2005; 128; 1187-1198.
10. Yantiss RK, Odze RD, Farraye FA, Rosenberg AE. Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am. J. Surg. Pathol. 2003; 27; 811-817.
11. Katona TM, Jones TD, Wang M, Abdul-Karim FW, Cummings OW, Cheng L. Molecular evidence for independent origin of multifocal neuroendocrine tumors of the enteropancreatic axis. Cancer Res. 2006; 66; 4936-4942.
12. Moyana TN, Satkunam N. A comparative immunohistochemical study of jejunoileal and appendiceal carcinoids. Cancer 1992; 70; 1081-1088.
13. Cross SS, Hughes AD, Williams GT, Williams ED. Endocrine cell hyperplasia and appendiceal carcinoids. J. Pathol. 1988; 156; 325-329.
14. Greenstein AJ, Balasubramanian S, Harpaz N, Rizwan M, Sachar DB. Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am. J. Gastroenterol. 1997; 92; 682-685.
15. Matsumoto T, Jo Y, Mibu R, Hirahashi M, Yao T, Iida M. Multiple microcarcinoids in a patient with long standing ulcerative colitis. J. Clin. Pathol. 2003; 56; 963-965.
16. Furlan D, Cerutti R, Uccella S et al. Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract. Clin. Cancer Res. 2004; 10; 947-957.
17. Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM. The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 2005; 104; 2292-2309.
18. Görtz B, Roth J, Krähenmann A et al. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am. J. Pathol. 1999; 154; 429-436.
19. D'Adda T, Pizzi S, Azzoni C et al. Different patterns of 11q allelic losses in digestive endocrine tumors. Hum. Pathol. 2002; 33; 322-329.
20. Pizzi S, Azzoni C, Bottarelli L et al. RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours. J. Pathol. 2005; 206; 409-416.
21. Pizzi S, D'Adda T, Azzoni C et al. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours. J. Pathol. 2002; 196; 401-407.
22. Kytola S, Nord B, Elder EE et al. Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas. Genes Chromosomes Cancer 2002; 34; 325-332.
23. Wang GG, Yao JC, Worah S et al. Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors. Mod. Pathol. 2005; 18; 1079-1087.
24. Chan AO, Kim SG, Bedeir A, Issa JP, Hamilton SR, Rashid A. CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 2003; 22; 924-934.
25. Wang DG, Johnston CF, Buchanan KD. Oncogene expression in gastroenteropancreatic neuroendocrine tumors - implications for pathogenesis. Cancer 1997; 80; 668-675.
26. Papouchado B, Erickson LA, Rohlinger AL et al. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas. Mod. Pathol. 2005; 18; 1329-1335.
27. Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1995; 425; 547-560.
28. Uccella S, Cerutti R, Vigetti D et al. Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis. J. Histochem. Cytochem. 2006; 54; 863-875.
29. Jakobsen AM, Ahlman H, Wangberg B, Kolby L, Bengtsson M, Nilsson O. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas. J. Pathol. 2002; 196; 44-50.
30. Srivastava A, Padilla O, Fischer-Colbrie R, Tischler AS, Dayal Y. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids. Am. J. Surg. Pathol. 2004; 28; 1371-1378.
31. Papotti M, Bongiovanni M, Volante M et al. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch. 2002; 440; 461-475.
32. Körner M, Eltschinger V, Waser B, Schonbrunn A, Reubi JC. Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: lessons from the comparison of antisst2A antibodies with somatostatin receptor autoradiography. Am. J. Surg. Pathol. 2005; 29; 1642-1651.
33. Solcia E, Kloppel G, Sobin LH et al. Histopathological typing of endocrine tumors. World Health Organisation international histological classification of tumors. Berlin, Heidelberg: Springer-Verlag 2000; 61-68.
34. Ramage JK, Davies AHG, Ardill J et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54 (Suppl. IV); iv1-iv16.
35. Plöckinger U, Rindi G, Arnold R et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. Neuroendocrinology 2004; 80; 394-424.
36. Rindi G, Azzoni C, Larosa S et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 1999; 116; 532-542.
37. Canavese G, Azzoni C, Pizzi S et al. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. Hum. Pathol. 2001; 32; 1094-1101.
38. Bordi C, D'Adda T, Pizzi S, Crafa P, Rindi G. The assessment of malignancy in endocrine tumours of the gastrointestinal tract. Curr. Diagn. Pathol. 2002; 8; 421-429.
39. Prinz C, Zanner R, Gratzl M. Physiology of gastric enterochromaffin-like cells. Annu. Rev. Physiol. 2003; 65; 371-382.
40. Rindi G, Luinetti O, Cornaggia M et al. Three subtypes of gastric argyrophil carcinoid and the neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993; 104; 994-1006.
41. Capella C, Solcia E, Sobin LH, Arnold R. Endocrine tumors of the stomach. In Hamilton SR, Aaltonen LA eds. Pathology and genetics of tumours of the digestive system. World Health Organization classification of tumours, Vol. 2. Lyon: IARC Press 2000; 53-57.
42. Abraham SC, Carney JA, Ooi A et al. Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder. Am. J. Surg. Pathol. 2005; 29; 969-975.
43. Müller J, Kirchner T, Müller-Hermelink HK. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am. J. Surg. Pathol. 1987; 11; 909-917.
44. Solcia E, Fiocca R, Villani L et al. Hyperplastic, dysplastic and neoplastic enterochromaffin-like cell proliferations of the gastric mucosa: classification and histogenesis. Am. J. Surg. Pathol. 1995; 19 (Suppl. 1); S1-S7.
45. Carney JA, Go VLW, Fairbanks VF et al. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann. Intern. Med. 1983; 99; 761-766.
46. Borch K, Renvall H, Kullman E et al. Gastric carcinoid associated with the syndrome of hypergastrinaemic atrophic gastritis. Am. J. Surg. Pathol. 1987; 11; 435-444.
47. Barrett P, Hobbs RC, Coates PJ, Risdon RA, Wright NA, Hall PA. Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem. J. 1995; 27; 482-486.
48. Ordonez N, Mackay B, El-Naggar A et al. Clear cell carcinoid tumour of the stomach. Histopathology 1993; 22; 190-193.
49. Harvey RF. Spontaneous resolution of multifocal gastric enterochromaffin-like cell carcinoid tumours. Lancet 1988; i; 821.
50. Dakin GF, Warner RR, Pomp A, Salky B, Inabnet WB. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors. J. Surg. Oncol. 2006; 93; 368-372.
51. Borch K, Ahren B, Ahlman H et al. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann. Surg. 2005; 242; 64-73.
52. Rindi G, Bordi C, Rappel S et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J. Surg. 1996; 20; 168-172.
53. Solcia E, Capella C, Fiocca R. et al. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. Am. J. Surg. Pathol. 1990; 14; 503-513.
54. Ooi A, Ota M, Katsuda S et al. An unusual case of multiple gastric carcinoids associated with diffuse endocrine cell hyperplasia and parietal cell hypertrophy. Endocr. Pathol. 1995; 3; 229-237.
55. Thomas RM, Baybick JH, Elsayed AM et al. Gastric carcinoids: an immunohistochemical and clinicopathologic study of 104 patients. Cancer 1994; 73; 2053-2058.
56. Roberts LJ, Bloomgarden ZT, Marvey SR, Rabin D, Oates JA. Histamine from the gastric carcinoid provocation by pentagastrin and inhibition by somatostatin. Gastroenterology 1983; 84; 272-275.
57. Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch. Pathol. Lab. Med. 1998; 122; 1010-1017.
58. Jiang S-X, Mikami T, Umezawa A, Saegusa M, Kameya T, Okayasu I. Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity. Am. J. Surg. Pathol. 2006; 30; 945-953.
59. Griffiths DFR, Williams GT, Williams ED. Multiple endocrine neoplasia associated with von Recklinghausen's disease. BMJ 1983; 287; 1341-1343.
60. Dayal Y, Tallberg KA, Nunnemacher G et al. Duodenal carcinoids in patients with and without neurofibromatosis. Am. J. Surg. Pathol. 1986; 10; 348-357.
61. Griffiths DFR, Williams GT, Williams ED. Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes. Quart. J. Med. (New Series) 1987; 64; 769-782.
62. Stephens M, Williams GT, Jasani B, Williams ED. Synchronous duodenal neuroendocrine tumours in von Recklinghausen's disease - a case report of co-existing gangliocytic paraganglioma and somatostatin-rich glandular carcinoid. Histopathology 1987; 11; 1331-1340.
63. Usui M, Matsuda S, Suzuki H, Hirata K, Ogura Y, Shiraishi T. Somatostatinoma of the papilla of Vater with multiple gastrointestinal stromal tumors in a patient with von Recklinghausen's disease. J. Gastroenterol. 2002; 37; 947-953.
64. Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Somatostatin-producing duodenal carcinoids in patients with von Recklinghausen's neurofibromatosis. A predilection for black patients. Cancer 1990; 65; 1591-1595.
65. Dayal Y, Doos WG, O'Brien MJ et al. Psammomatous somatostatinomas of the duodenum. Am. J. Surg. Pathol. 1983; 7; 653-665.
66. Griffiths DFR, Jasani B, Newman GR, Williams ED, Williams GT. Glandular duodenal carcinoid - a somatostatin rich tumour with neuroendocrine associations. J. Clin. Pathol. 1984; 37; 163-169.
67. Makhlouf HR, Burke AP, Sobin LH. Carcinoid tumors of the ampulla of Vater - a comparison with duodenal carcinoids. Cancer 1999; 85; 1241-1249.
68. Swinburn BA, Yeong ML, Lane MR et al. Neurofibromatosis associated with somatostatinoma: a report of two patients. Clin. Endocrinol. 1988; 28; 353-359.
69. Federspiel BH, Burke AP, Sobin LH, Shekitka KM. Rectal and colonic carcinoids: a clinicopathologic study of 84 cases. Cancer 1990; 65; 135-140.
70. Iwafuchi M, Watanabe H, Ajioka Y, Shunoda T, Iwashinda A, Ito S. Immunohistochemical and ultrastructural studies of twelve argentaffin and six argyrophil carcinoids of the appendix vermiformis. Hum. Pathol. 1990; 21; 717-725.
71. Shaw PAV, Pringle JH. The demonstration of a subset of carcinoid tumors of the appendix by in situ hybridization using synthetic probes to proglucagon mRNA. J. Pathol. 1992; 167; 375-380.
72. Fahrenkamp AG, Wibbeke C, Winde G et al. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract. Virchows Arch. 1995; 426; 361-367.
73. Portela-Gomes GM, Stridsberg M, Johansson H, Grimelius L. Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract. J. Histochem. Cytochem. 1997; 45; 815-822.
74. Burke AP, Sobin LH, Shekitka KM, Helwig EB. Goblet cell carcinoids and related tumors of the vermiform appendix. Am. J. Clin. Pathol. 1990; 94; 27-35.
75. Kobayashi K, Katsumata T, Yoshizawa S et al. Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography. Dis. Colon Rectum 2005; 48; 285-291.